Risk factors

Big Sky Industrial faces heavy commodity price volatility impacting oil, gas, and NGL operations. The company relies heavily on unproven exploration projects in the Kevin Dome Structure in Montana. Operations are geographically concentrated in Montana, Wyoming, Texas, and Oklahoma.

Candel Therapeutics faces extensive financial losses with no commercial revenue, relying heavily on the success of its lead viral immunotherapies CAN-2409 and CAN-3110.

Heavy reliance on approximately 3,300 offshore employees in Pakistan for operations, customer support, and software development. Revenue depends significantly on customer billing recovery percentages and contracts tied to Mahmud Haq and executive leadership. Exposure to credit facility expiration in October 2025 and recent goodwill impairment charges.

International policyholders account for approximately 67% of direct insurance premiums as of December 31, 2024, driving primary foreign and regulatory risks. Dependence on a small number of independent consulting and marketing agencies creates major distribution vulnerabilities. A capital maintenance agreement with the Colorado Division of Insurance requires keeping CICA Domestic RBC above 350%.

CION Investment Corp faces significant risks relying on external manager CIM for investment decisions and fee generation. The company concentrates its portfolio in private middle-market debt and equity with limited liquidity and high exposure to interest rate fluctuations. Regulatory compliance under the 1940 Act and tax rules heavily restricts capital raising and investment flexibility.

Operating cash of $23.3 million funds operations only into the fourth quarter of 2025. Financial statement restatements for 2022 and 2023 expose the company to legal and regulatory risks. Dependence on third-party contract research organizations and outsourced manufacturing creates operational vulnerabilities.

Century Casinos faces significant debt obligations under its Master Lease, intensive competition, and strict multi-jurisdictional gaming regulations.

Clinical-stage biopharmaceutical company dependent entirely on the success and regulatory approval of its sole product candidate, tecarfarin. Requires substantial additional capital to fund upcoming pivotal Phase 3 clinical trials and secure manufacturing. Operates with a limited history and relies heavily on third-party contractors for clinical trials and supply.

Credit losses are central, especially in commercial real estate, commercial, and agricultural lending across Wisconsin and Minnesota.

Fidelity D & D Bancorp operates primarily in Lackawanna and Luzerne Counties in Pennsylvania. Key risks center on commercial real estate volatility, net interest income dependency, and regulatory capital rules under Basel III and Dodd-Frank.

This filing reflects an initial public presentation of a business with significant customer concentration, heavy reliance on external management by Fortress, and specific operational risks in rail, energy, and port infrastructure.

Funko's business is dominated by third-party licenses, overseas contract manufacturing, high inventory volatility, and significant debt obligations.